Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 31;14(1):e21781.
doi: 10.7759/cureus.21781. eCollection 2022 Jan.

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study

Neha Mishra  1 , Ruchi Verma  1 , Payal Jadaun  2
Affiliations

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study

Neha Mishra et al. Cureus. .

Abstract

Objective: This study was conducted to see the effects of berberine, metformin, and myoinositol in women with polycystic ovary syndrome (PCOS).

Materials and methods: Subjects were randomly assigned via computer-generated randomization to one of the three treatment groups. Group 1 received berberine hydrochloride 500 mg twice daily, group 2 received metformin hydrochloride 500 mg twice daily, and group 3 received myoinositol 1000 mg twice daily to compare clinically (mean weight, waist circumference, waist-to-hip ratio, and body mass index), metabolic (fasting blood sugar, serum fasting insulin, fasting blood sugar/serum fasting insulin [FBS/FI]), hormonal effects (serum total testosterone [TT], serum sex hormone-binding globulin [SHBG] and free androgen index) together with the lipid profile (total cholesterol, serum triglyceride, serum low-density lipoprotein [LDL], very-low-density lipoprotein [VLDL], serum high-density lipoprotein [HDL]) in patients receiving metformin, berberine, and myoinositol before and after three months of treatment.

Results: Weight, BMI, waist circumference, waist-hip ratio, FBS, FI and fasting glucose/insulin ratio, total testosterone, free androgen index (FAI), SHBG, total cholesterol, triglycerides, LDL, VLDL, and HDL showed significant differences in three groups after three months of treatment (p<0.0001). Between the three groups, berberine showed greater differences in clinical, hormonal, and lipid parameters compared to metformin and myoinositol, while myoinositol showed greater improvement in carbohydrate metabolic parameters.

Conclusions: Metformin, the classical drug used in PCOS, improves all the parameters in polycystic ovary syndrome women. Berberine may have greater potential to reduce the risk of cardiovascular disease than metformin in PCOS patients due to its effect on body composition, lipid profile, and improvement in hormone status. Myoinositol administration improves endocrine parameters and insulin sensitivity. It may be considered as a first-line option in PCOS patients with insulin resistance without prediabetes or diabetes.

Keywords: berberine; free androgen index; metformin; myo-inositol; polycystic ovary syndrome (pcos); serum fasting insulin; sex hormone binding globulin; waist circumference; waist hip ratio.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Recruitment flow chart
See this image and copyright information in PMC

References

    1. Polycystic ovary syndrome - a metabolic malady, the mother of all lifestyle disorders in women - can Indian health budget tackle it in future? Ganie MA, Kalra S. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193771/ Indian J Endocrinol Metab. 2011;15:239–241. - PMC - PubMed
    1. Investigating fetuin-a and paraoxonase-1 activity as markers in polycystic ovary syndrome based on body mass index: a prospective case-control study. Gurbuz T, Alanya Tosun S, Cebi A, Gokmen O, Usta M. Cureus. 2021;13:0. - PMC - PubMed
    1. Cellular and molecular mechanisms of metformin: an overview. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Clin Sci (Lond) 2012;122:253–270. - PMC - PubMed
    1. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Wei W, Zhao H, Wang A, et al. Eur J Endocrinol. 2012;166:99–105. - PubMed
    1. The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review. Li MF, Zhou XM, Li XL. Evid Based Complement Alternat Med. 2018;2018:2532935. - PMC - PubMed